U.S. Aerospace & Defense Stock News

With the U.S. slapping 50% tariffs on selected Canadian imports and Canada firing back with dollar for dollar measures, cross border supply chains are under fresh pressure. That kind of shock can hurt some stocks and create room for others that are tied more closely to U.S. manufacturing and onshoring. This article walks through 3 stocks exposed to this news and how the shifting trade backdrop could matter for their stories. The stocks covered below are just a starting sample. The full screen...

Cytokinetics (CYTK) has drawn fresh attention after disclosing that it will present favorable topline results from its ACACIA-HCM Phase 3 aficamten trial at the European Society of Cardiology Congress 2026, a potentially meaningful clinical milestone. See our latest analysis for Cytokinetics. Cytokinetics shares trade at US$76.84 after a 1 day share price return that declined 0.44%, with a 7 day share price return of 3.66% but a 30 day share price return that fell 6.51%. Even so, the 1 year...

Roblox stock has had a tough run over the past year, yet current valuation checks still suggest the shares are not a clear bargain even after that pullback. Roblox has declined 67.4% over the past year, which raises the question of whether recent weakness has been fully reflected in the current share price. Expectations for user and revenue growth can support the case for paying up for Roblox, while the ongoing investigation into alleged misrepresentations by certain officers and directors...

Applied Digital (APLD) is back in focus after signing a 15 year lease for 210 megawatts of IT load at its Delta Forge 2 AI campus, securing multibillion dollar contracted revenue with a new institutional holder entering the stock. See our latest analysis for Applied Digital. The lease news comes during a period of pressure on Applied Digital’s share price, which is down 40.68% over the past 90 days and 9.54% over the past 30 days. Over a 1-year period, the total shareholder return is 69.53%,...

XP Inc. has already reported its second-quarter 2026 results, with revenue rising to R$4.85 billion and net income reaching R$1.38 billion, alongside modestly higher diluted EPS and the completion of two share repurchase programs totaling about R$1.21 billion. Management also revealed it is weighing the creation or acquisition of a U.S. banking operation, a move that could reshape XP’s business mix and broaden its international reach while adding regulatory and execution complexity. We’ll...

Chubb (CB) is back on investors’ radar after reporting second quarter 2026 core operating earnings of $7.26 per share that exceeded estimates, along with a recently affirmed quarterly dividend of $1.02 per share. See our latest analysis for Chubb. At a share price of $340.99, Chubb’s share price return has eased slightly in the very short term. However, the 90 day share price return of 4% and 1 year total shareholder return of 24.36% suggest momentum has been building over a longer period,...

Sezzle (SEZL) has drawn fresh attention after reporting 76.4% year-over-year growth in its subscriber base to 854,000 in the second quarter of 2026, alongside rapid progress in AI driven products and customer tools. See our latest analysis for Sezzle. Sezzle's recent subscriber and AI updates arrive after a mixed stretch for the stock, with a 1 day share price return of 1.44% at a US$119.11 close, a 30 day share price decline of 31.64%, and a 3 year total shareholder return of about 7x that...

Atlassian stock has surged over the past month, yet the valuation signals are more muted, with the Discounted Cash Flow (DCF) intrinsic value estimate pointing to a price that is close to where the shares currently trade, while the market multiple view still screens the stock as undervalued. Atlassian is up 101.2% over the past month, which puts recent price momentum well ahead of its longer term return record. Recent enthusiasm around Atlassian's Rovo AI and related product developments can...

Why USA Rare Earth Stock Is Back In Focus After Q2 Results USA Rare Earth (USAR) moved back onto investor watchlists after its second quarter 2026 earnings release on 10 August, which showed sales of US$5.82 million and a net loss of US$10.33 million. The company followed that update with back to back conference appearances at Canaccord Genuity's Growth Conference on 11 August and the Needham Virtual Industrial Tech, Robotics, and Power 1x1 Conference on 17 August, keeping attention on its...

BILL Holdings (BILL) is back on investor radar after fiscal fourth quarter and full year results topped consensus forecasts, coupled with new 2027 guidance that points to slower core revenue growth but higher profitability and Rule of 40 ambitions. See our latest analysis for BILL Holdings. The latest earnings beat and 2027 guidance arrive after a sharp rebound in BILL Holdings’ share price, with a 30 day share price return of 14.16% and a 90 day share price return of 32.32%. That recent...

HP (NYSE: HPQ) gaming brand HyperX announced a new lineup of peripherals, including the Cloud Alpha Air headset and Pulsefire Haste 3 Pro wireless mouse. The refreshed range adds an open back headset design, updated audio technology, and ultra lightweight wireless mice to HyperX's catalog. The launch expands HP's presence in high performance gaming gear beyond its established PC and printing products. Investors are watching how the broader HyperX suite might affect HP's position in the...

Virtus Investment Partners (VRTS) is back in focus after converting two Zevenbergen mutual funds into actively managed ETFs and announcing a higher quarterly dividend, developments that may influence how you think about the stock today. See our latest analysis for Virtus Investment Partners. Over the past year, Virtus Investment Partners has seen its share price show shorter term momentum, with a 90 day share price return of 16.34%, even as the 1 year total shareholder return declined 11.31%...

Lamb Weston Holdings stock has enjoyed a strong rebound this year, yet its recent history and valuation checks suggest investors may still be paying up for the shares. After a three year period where the stock declined 40.1%, the current pricing raises questions about how much of a recovery is already reflected in the market value. Over the past 3 years, Lamb Weston Holdings has delivered a 40.1% decline, which points to a challenging stretch for long term holders even with the more recent...

CF Industries Holdings (CF) climbed 5.5% as fertilizer stocks moved together on renewed optimism around commodity fundamentals, shifting natural gas costs, crop planting expectations, and ongoing concerns about global food security. See our latest analysis for CF Industries Holdings. The latest move in CF Industries Holdings adds to a pattern of strong recent momentum, with a 7 day share price return of 9.55% and a year to date share price return of 61.74%, alongside a 5 year total...

With Treasury yields hovering near multi year highs and rate cuts looking less certain, investors are weighing what higher borrowing costs and a stronger dollar could mean for long term portfolios. This is creating an opening for those who care about steady income and valuation discipline but also feel the recent pullback in equities might be overdone in places. This article walks through three dividend payers from our high quality screener that appear well aligned with the latest macro...

Vertex Pharmaceuticals (VRTX) lifted its full year 2026 revenue guidance after citing continued demand in cystic fibrosis treatments and broader uptake in sickle cell disease, beta thalassemia, and acute pain therapies. See our latest analysis for Vertex Pharmaceuticals. The guidance upgrade comes after a strong run in Vertex Pharmaceuticals stock, with a 30 day share price return of 15.97% and a 90 day share price return of 26.13%. The 1 year total shareholder return of 38.70% and 5 year...

Best Buy recently reported quarterly results for the period ended July 2026, with Wall Street having anticipated higher year-over-year earnings supported by increased revenues and the possibility of an earnings beat based on a positive Earnings ESP. This setup highlighted how even small differences between the Most Accurate Estimate and the broader consensus can meaningfully shift expectations around Best Buy’s near-term earnings momentum. Next, we’ll examine how the anticipated earnings...

ZIM Integrated Shipping Services (ZIM) caught investor attention after reporting second quarter 2026 net income of US$63.5 million, higher freight rates, increased container volumes, revenue growth, and reaffirmed full year guidance with a potential dividend. See our latest analysis for ZIM Integrated Shipping Services. At a share price of US$28.25, ZIM Integrated Shipping Services has seen a 12.95% 1 month share price return and a 28.94% year to date share price return, while the 1 year...

Rare Element Resources (OTCPK:REEM.F) moved into focus after the company addressed online market research materials suggesting a possible new investment and an announcement as early as August 26, 2026. See our latest analysis for Rare Element Resources. The sharp 1 day share price decline of 28.45% and 7 day share price fall of 7.97% came after Rare Element Resources clarified that online speculation about a potential investment was unfounded. However, the 30 day share price return of 176.13%...

PHINIA (PHIN) shares are trading against a backdrop of leadership and segment changes after the company appointed Pedro Abreu as President of Power Systems and Daniel Griffin as President of Aftermarket Solutions. See our latest analysis for PHINIA. At a share price of US$72.75, PHINIA has had a 1 day share price return of 1.56%, while the 30 day share price return is down 8.77% and the 1 year total shareholder return is 26.52%. This suggests that longer term momentum has held up even as the...

HCA Healthcare recently reported a solid Q2 2026 performance with strong revenue and patient-volume growth, even as it trimmed its full-year outlook to reflect payer and service-mix pressures. Alongside plans to present at several upcoming healthcare conferences and continued investment in emergency care capacity, HCA is signaling an emphasis on operational efficiency and technology as it balances growth with reimbursement headwinds. Next, we will examine how HCA’s strong quarterly results...

Moderna (NasdaqGS:MRNA) and Merck reported a successful Phase 3 trial of their personalized mRNA cancer vaccine, intismeran, in high risk melanoma patients. The vaccine, used with Merck's immunotherapy Keytruda, significantly reduced the risk of melanoma recurrence and spread compared with Keytruda alone. This is the first late stage oncology trial success for an mRNA therapy and could support upcoming regulatory discussions, including potential FDA review. The partners indicated that these...

Apple (NasdaqGS:AAPL) is cutting over 200 roles across its Siri and Vision Pro teams as part of a restructuring to accelerate artificial intelligence work. The layoffs affect both hardware and AI groups and coincide with a shift in the product roadmap toward smart glasses and broader intelligent systems. Apple is moving resources away from immersive video and gaming efforts within Vision Pro to concentrate on longer term AI driven projects. This repositioning around AI at Apple fits into a...

Kimbell Royalty Partners (NYSE:KRP) closed a US$221.2 million acquisition, expanding its mineral and royalty interests in key US oil and gas basins. The transaction increases Kimbell's asset base and exposure to production cash flows tied to these properties. The deal represents a material development for investors focused on US energy royalty and mineral exposure. For readers interested in more ways to play resource linked cash flows, the next useful step is to review 28 best rare earth...